It has been demonstrated that gefitinib-resistant lung cancer cells exhibited strong sphere-forming activity and high CXCR4 expression, and isolated CXCR4-positive cells were responsible for the features of CSCs [26]. This evidence concerns the gene CXCR4 and lung carcinoma.